The burgeoning landscape of novel treatments for weight management has seen the rise of both retatrutide and tirzepatide, both dual mode agonists targeting the GLP-1 and GIP receptors. While sharing a alike therapeutic https://kallumasrv234236.wikinewspaper.com/4298084/retatrutide_vs_tirzepatide_a_comparative_analysis